FITC-Linked Polyclonal Antibody to Cathepsin K (CTSK) Sus scrofa; Porcine (Pig) Labelled antibody

CTS-K; CTS02; CTSO; CTSO1; CTSO2; PKND; PYCD; Pycnodysostosis; Cathepsin O; Cathepsin X

Add to Cart Distributors
Overview
Properties
  • SourceAntibody labeling
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelFITC
  • Original Antibody n/a
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid, Concentration 500µg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • FITC-Linked Polyclonal Antibody to Cathepsin K (CTSK) Packages (Simulation)
  • FITC-Linked Polyclonal Antibody to Cathepsin K (CTSK) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a rabbit polyclonal antibody raised against CTSK. It has been selected for its ability to recognize CTSK in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • MRMT-1 rat breast carcinoma cells and models of bone metastases: improvement of an in vitro system to mimic the in vivo condition.PubMed: S0065128112000773
  • Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid arteryPubmed:24534452
  • Drynaria total flavonoids decrease cathepsin K expression in ovariectomized ratsPubmed:25036175
  • In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytesPubMed: 26250906
  • Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary TuberculosisPubMed: 26416658
  • Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritispmc:PMC4822855
  • TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42Pubmed:29358671
  • Comparative evaluation of cathepsin K levels in gingival crevicular fluid among smoking and nonsmoking patients with chronic periodontitisPubmed: 30409937
  • A bioactive exopolysaccharide from marine bacteria Alteromonas sp. PRIM-28 and its role in cell proliferation and wound healing in vitroPubmed: 30851325
  • Biomarkers of Compromised Implant Fixation
  • Compound K induces neurogenesis of neural stem cells in thrombin induced nerve injury through LXRα signaling in micePubmed: 32371156
  • Информационный алгоритм неинвазивной оценки остеорезорбтивного побочного действия глюкокортикостероидов у больных язвенным колитом
  • Особенности остеоиммунологических аспектов остеорезорбции при периимплантите, хроническом пародонтите и раке альвеолярного отростка и …

Recommend products